The expression of p33ING1, p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer

Autophagy as a therapeutic target in cancer

(2011) Ning Chen et al.   CANCER BIOLOGY & THERAPY

Autophagy: Molecular Mechanisms and their Implications for Anticancer Therapies

(2011) S. Meschini et al.   CURRENT CANCER DRUG TARGETS

Pharmacological Activation of p53 in Cancer Cells

(2011) Mohammad Athar et al.   CURRENT PHARMACEUTICAL DESIGN

p53 and its mutants in tumor cell migration and invasion

(2011) Patricia A. J. Muller et al.   JOURNAL OF CELL BIOLOGY

Mutant p53R175H upregulates Twist1 expression and promotes epithelial–mesenchymal transition in immortalized prostate cells

(2010) I Kogan-Sakin et al.   CELL DEATH AND DIFFERENTIATION

Autophagy: cancer therapy’s friend or foe?

(2010) Dan Grandér et al.   Future Medicinal Chemistry

p53: The Attractive Tumor Suppressor in the Cancer Research Field

(2010) Toshinori Ozaki et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

ING function in apoptosis in diverse model systemsThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB’s 51st Annual Meeting – Epigenetics and Chromatin Dynamics, and has undergone the Journal’s usual peer review process.

(2009) Sitar Shah et al.   Biochemistry and Cell Biology

Role and regulation of autophagy in cancer

(2009) Ning Chen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis

(2009) Maddalena Adorno et al.   CELL

Potential Usage of ING Family Members in Cancer Diagnostics and Molecular Therapy

(2009) Mehmet Gunduz et al.   CURRENT DRUG TARGETS

ING Proteins in Cellular Senescence

(2009) Camino Menendez et al.   CURRENT DRUG TARGETS

Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer

(2009) Kyu Yeoun Won et al.   HUMAN PATHOLOGY

The Inhibitor of Growth (ING) Gene Family: Potential Role in Cancer Therapy

(2008) Mehmet Gunduz et al.   CURRENT CANCER DRUG TARGETS